66 related articles for article (PubMed ID: 1982079)
1. [THe selective effect of neuroleptics on a dopamine-dependent behavioral disorder in rats in the extrapolation escape test].
Bondarenko NA
Biull Eksp Biol Med; 1990 Nov; 110(11):506-8. PubMed ID: 1982079
[TBL] [Abstract][Full Text] [Related]
2. [Behavior disorder in rats induced by Madopar and its pharmacological correction].
Bondarenko NA; Bondarenko NA
Farmakol Toksikol; 1985; 48(4):31-4. PubMed ID: 2864283
[TBL] [Abstract][Full Text] [Related]
3. [Model of the defense reaction in rats to study the antifenamine effect of neuroleptics for demonstrating their specific action].
Baturin VA; Iuntsev SV
Farmakol Toksikol; 1984; 47(5):110-3. PubMed ID: 6149952
[TBL] [Abstract][Full Text] [Related]
4. [Behavioral assessment of neuroleptics (1)--Active avoidance response].
Kuribara H
Yakubutsu Seishin Kodo; 1991 Oct; 11(5):297-304. PubMed ID: 1688173
[TBL] [Abstract][Full Text] [Related]
5. Cognitive deficiency induced by the acute stress in rats: a possible role of brain catecholaminergic systems.
Rayevsky KS; Bondarenko NA; Kudrin VS; Miroshnichenko II
Ann Ist Super Sanita; 1990; 26(1):25-9. PubMed ID: 2118320
[TBL] [Abstract][Full Text] [Related]
6. [Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics].
Zharkovskiĭ AM; Langel IuL; Chereshka KS; Zharkovskaia TA
Biull Eksp Biol Med; 1987 Mar; 103(3):317-9. PubMed ID: 2881585
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
[TBL] [Abstract][Full Text] [Related]
8. [Removal of the optimizing action of neuroleptics on the avoidance behavior of rats after striatectomy].
Arushanian EB; Baturin VA
Farmakol Toksikol; 1979; 42(3):230-4. PubMed ID: 36296
[TBL] [Abstract][Full Text] [Related]
9. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
10. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
Eltayb A; Wadenberg ML; Svensson TH
Biol Psychiatry; 2005 Aug; 58(4):337-43. PubMed ID: 16102547
[TBL] [Abstract][Full Text] [Related]
12. [The agonists of I-A serotoninergic receptors restore in rats behavior impaired by L-dihydroxyphenylalanine].
Bondarenko NA; Bondarenko NA; Baran L; Klodzinska A
Biull Eksp Biol Med; 1990 Dec; 110(12):627-8. PubMed ID: 2083366
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological analysis of hypothalamically-induced emotions.
Korelli AG; Davituliani DS
Acta Physiol Hung; 1988; 72(3-4):307-13. PubMed ID: 2907959
[TBL] [Abstract][Full Text] [Related]
14. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
Fredriksson A; Archer T
Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
[TBL] [Abstract][Full Text] [Related]
15. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
16. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
[TBL] [Abstract][Full Text] [Related]
17. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
18. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
Matsushita N; Misu Y; Goshima Y
Eur J Pharmacol; 2009 Mar; 605(1-3):109-13. PubMed ID: 19168057
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics.
Koek W; Colpaert FC
J Pharmacol Exp Ther; 1993 Oct; 267(1):181-91. PubMed ID: 7901392
[TBL] [Abstract][Full Text] [Related]
20. Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Worms P
Adv Biochem Psychopharmacol; 1982; 35():7-16. PubMed ID: 6128876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
